Home Cart Sign in  
Chemical Structure| 394694-98-5 Chemical Structure| 394694-98-5

Structure of MitoBloCK-10
CAS No.: 394694-98-5

Chemical Structure| 394694-98-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

MitoBloCK-10 is the first small molecule modulator to attenuate PAM (protein-associated motor) complex activity. It binds to a specific pocket in the C-terminal domain of Tim44 of the PAM complex.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of MitoBloCK-10

CAS No. :394694-98-5
Formula : C12H8FN3O3S
M.W : 293.27
SMILES Code : O=C(NN=CC=1SC(=CC1)N(=O)=O)C=2C=CC=C(F)C2
MDL No. :MFCD00813373

Safety of MitoBloCK-10

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Primary bladder epithelial cells (priBEC) 25 μM 24 hours No significant effect on cell viability and death Cell Death Dis. 2024 Mar 11;15(3):204
T24 bladder cancer cells 25 μM 24 hours Inhibited cell viability, proliferation, and motility, induced apoptosis Cell Death Dis. 2024 Mar 11;15(3):204
hCMEC/D3 25μM 48 hours MB-10 inhibited proliferation and migration in hCMEC/D3 cells, leading to mitochondrial dysfunction. Cell Death Dis. 2023 May 5;14(5):307
hRMECs 25μM 48 hours MB-10 inhibited proliferation and migration in hRMECs, leading to mitochondrial dysfunction. Cell Death Dis. 2023 May 5;14(5):307
HUVECs 25μM 48 hours MB-10 inhibited proliferation, migration, and in vitro capillary tube formation in HUVECs, leading to mitochondrial dysfunction, including reduced ATP and increased ROS production. Cell Death Dis. 2023 May 5;14(5):307

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice Bladder cancer xenograft model Intraperitoneal injection 20 mg/kg Every 48 hours for a total of three doses Inhibited bladder cancer xenograft growth, induced oxidative stress, ATP reduction, and Akt-S6K1 inhibition Cell Death Dis. 2024 Mar 11;15(3):204
C57BL/6 mice Retinal angiogenesis model Intravitreal injection 0.25 nM Single injection, lasting 72 hours MB-10 inhibited retinal angiogenesis in mice, leading to increased vascular leakage and acellular capillaries. Cell Death Dis. 2023 May 5;14(5):307

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.41mL

0.68mL

0.34mL

17.05mL

3.41mL

1.70mL

34.10mL

6.82mL

3.41mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories